© Copyright Our Wall
Roots Analysishas done a detailed study
on Cell Free System: Cell Free Expression Kits and Service Providers,
2023-2035, covering key aspects of the industry’s evolution and identifying
potential future growth opportunities.
Key Market Insights
§
Presently,
more than 35 players across the globe claim to offer cell free expression
services for synthesis of a variety of biomolecules
§
The
current market landscape is fragmented, featuring the presence of both new
entrants and established players catering to needs of various industries;
majority of these players are based in the US
§
In
pursuit of building a competitive edge in this field, stakeholders are actively
upgrading their existing capabilities and adding new competencies in order to
enhance their respective service portfolios
§
More
than 90 cell free expression kits are currently available in the market for the
synthesis of different types of biomolecules; these kits utilize different
types of host organisms for cell free expression
§
Cell
free expression kits utilize a range of cell
free expression systemfor
the synthesis of different types of biologics; majority of these include
proteins, followed by oligonucleotides and others
§
Owing
to the rise in demand for difficult to express biomolecules, the requirement of
cell free expression is increasing, prompting the stakeholders to upgrade their
product offerings
§
Since
2015, more than 430 patents have been filed / granted by various stakeholders
in order to protect the intellectual property generated within this field
§
The
growing interest is evident from the rise in partnership activity; in fact, the
maximum number of collaborations related to cell
free systemswere inked
in 2022
§
Several
investors having realized the opportunity within this domain, have invested
more than USD 8 billion across various funding rounds in the past six years
§
The
cell free expression market is likely to grow at a CAGR of 7.1%, till 2035;
this opportunity is expected to be well distributed across different types of
cell free systems, host organisms and expression methods
§
Growth
in this domain is anticipated to be primarily driven by the rising demand for
biologics; North America is expected to capture larger share (over 50%) of the
market by 2035
Table of Contents
1. PREFACE
1.1. Cell
Free System Overview
1.2. Key
Market Insights
1.3. Scope
of the Report
1.4.
Research Methodology
1.5.
Frequently Asked Questions
1.6.
Chapter Outlines
2.
EXECUTIVE SUMMARY
3.
INTRODUCTION
3.1.
Chapter Overview
3.2. Introduction
to Cell Free Systems
3.3.
Overview of Cell Free Biomanufacturing
3.4.
Applications of Cell Free Biomanufacturing
3.5.
Future Perspectives
4. MARKET
LANDSCAPE: CELL FREE EXPRESSION SERVICE PROVIDERS
4.1.
Chapter Overview
4.2. Cell
Free Expression Service Providers: Overall Market Landscape
5. MARKET
LANDSCAPE: CELL FREE EXPRESSION KITS
5.1.
Chapter Overview
5.2. Cell
Free Expression Kits: Overall Market Landscape
5.3. Cell
Free Expression Kit Providers Landscape
6. CELL
FREE EXPRESSION SERVICE PROVIDERS: COMPANY COMPETITIVENESS ANALYSIS
6.1.
Chapter Overview
6.2.
Assumptions and Key Parameters
6.3.
Methodology
6.4.
Company Competitiveness Analysis: Cell Free Expression Service Providers
7. CELL
FREE EXPRESSION KITS: PRODUCT COMPETITIVENESS ANALYSIS
7.1.
Chapter Overview
7.2.
Assumptions and Key Parameters
7.3.
Methodology
7.4.
Product Competitiveness Analysis: Cell Free Expression Kits
8. COMPANY
PROFILES: CELL FREE EXPRESSION SERVICE PROVIDERS
8.1.
Chapter Overview
8.2. BioLinker
8.2.1.
Company Overview
8.2.2.
Cell Free Expression Service Portfolio
8.2.3.
Recent Developments and Future Outlook
8.3.
CUSABIO
8.4.
LenioBio
8.5.
Touchlight
9. COMPANY
PROFILES: CELL FREE EXPRESSION KIT PROVIDERS
9.1.
Chapter Overview
9.2.
biotechrabbit
9.3.
CellFree Sciences
9.4.
Creative Biolabs
9.5.
Diacel Arbor Biosciences
9.6.
Promega
9.7.
Thermo Fisher Scientific
10.
PARTNERSHIPS AND COLLABORATIONS
10.1.
Chapter Overview
10.2.
Partnership Models
10.3. Cell
free System: Partnerships and Collaborations
11.
FUNDING AND INVESTMENT ANALYSIS
11.1.
Chapter Overview
11.2.
Types of Funding
11.3. Cell
free System: Funding and Investment Analysis
12. PATENT
ANALYSIS
12.1.
Chapter Overview
12.2.
Scope and Methodology
12.3. Cell
free System: Patent Analysis
12.4. Cell
free System: Patent Benchmarking Analysis
12.5. Cell
free System: Patent Valuation
12.6.
Leading Patents: Analysis by Number of Citations
13. MARKET
FORECAST AND OPPORTUNITY ANALYSIS
13.1.
Chapter Overview
13.2. Key
Assumptions and Forecast Methodology
13.3.
Global Cell Free Market, 2023-2035
14.
EXECUTIVE INSIGHTS
14.1.
Chapter Overview
14.2. Gene
Frontier
14.3.
LenioBio
14.4.
Synthelis
15.CONCLUDING
REMARKS
16.
APPENDIX 1: TABULATED DATA
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
For
additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html
Learn from
experts: do you know about these
emerging industry trends?
Modular
Construction – Retrofitting Conventional Buildings
Long-Acting Drug
Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
About Roots Analysis
Roots Analysis is a global leader in the
pharma / biotech market research. Having worked with over 750 clients
worldwide, including Fortune 500 companies, start-ups, academia, venture
capitalists and strategic investors for more than a decade, we offer a highly
analytical / data-driven perspective to a network of over 450,000 senior
industry stakeholders looking for credible market insights.
Learn more about Roots
Analysis consulting services:
Roots Analysis Consulting - the
preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
The Wall